Trytosaveabit commented on a stock · Jan 8 06:48

News

$Arcutis Biotherapeutics(ARQT.US)$ Arcutis Canada Announces Health Canada Acceptance of the Supplement to a New Drug Submission for Roflumilast Foam 0.3% For Seborrheic Dermatitis in Individuals 9 Years of Age and Older
Benzinga· 3 mins ago

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

6496 Views

Comment

Trytosaveabit

1790Followers

29Following

21KVisitors